Aurora Cannabis (ACB) Equity Average (2025)

Aurora Cannabis (ACB) reported Equity Average of $409.6 million for Q4 2025, down 2.11% quarter-over-quarter from $418.5 million in Q3 2025.

Aurora Cannabis (ACB) Equity Average (2025) Analysis & Trends

Aurora Cannabis (ACB) has 1 years of Equity Average data on file, last reported at $409.6 million in Q4 2025.

Equity Average for Q4 2025 came in at $409.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $409.6 million (changed N/A YoY), and the FY2025 annual result was $419.8 million, changed N/A from the prior year.
Equity Average eased to $409.6 million in Q4 2025 per ACB's latest filing, from $418.5 million in the prior quarter.
Over five years, Equity Average peaked at $424.5 million in Q2 2025 and troughed at $409.6 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	8.07 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	3.32 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	6.50 Bn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	409.63 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	3.33 Bn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	6.52 Bn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	1.79 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	493.55 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	1.15 Bn
10	Liquidia	5.64 Bn	5.42 Bn	121.79 Mn	76.66 Mn

Download Data